USP's Matt Christian: Why Drug Shortages Are Becoming Longer—and Harder to Solve

Although the total number of US drug shortages declined in 2025, many shortages have become increasingly prolonged, highlighting persistent vulnerabilities throughout the pharmaceutical supply chain. In an interview with Pharmacy Times, Matt Christian, director of Supply Chain Insights at USP, discussed the factors driving long-term shortages, the growing role of geographic concentration, and what pharmacists should understand about supply chain resilience.